On January 5, 2024, Twist Bioscience Corporation announced the appointment of Adam Laponis as the principal financial officer, effective January 8, 2024. Mr. Laponis, age 47, previously served as the Chief Financial Officer of Eargo Inc. from June 2019 to January 2024. From November 2018 to March 2019, Mr. Laponis served as Vice President of Financial Planning and Analysis for Tesla where he previously served as Senior Director of Finance from April 2017 to November 2018.

Prior to that, he served as the Vice President and Chief Financial Officer of Cardiovascular Care of Cardinal Health from October 2015 to April 2017. Prior to that, he served in various financial roles at Johnson & Johnson, a healthcare company, from August 2004 to October 2015. Mr. Laponis holds a B.S. in Chemical Engineering from the University of California, Berkeley and an M.B.A. from the University of Southern California.